The five most worrying proposals of the pharmaceutical industry for the EU-US trade agreement is the focus of six international organizations concerned with health and medicines. They released a 15-page position paper on 3-24-14: "The Transatlantic Trade and Investment Partnership (TTIP): A Civil Society Response to the Big Pharma wish list." Longer monopolies and high prices are on the list. TTIP has the potential to trump local regulations designed to improve access and affordability. Focus on page 5. LEARN MORE.